Cargando…
Two Vaccines for Staphylococcus aureus Induce a B-Cell-Mediated Immune Response
Staphylococcus aureus causes severe disease in humans for which no licensed vaccine exists. A novel S. aureus vaccine (SA4Ag) is in development, targeting the capsular polysaccharides (CPs) and two virulence-associated surface proteins. Vaccine-elicited antibody responses to CPs are efficacious agai...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106056/ https://www.ncbi.nlm.nih.gov/pubmed/30135219 http://dx.doi.org/10.1128/mSphere.00217-18 |